Cosaic is a technology company.
Cosaic has raised $26.9M across 4 funding rounds.
Cosaic has raised $26.9M in total across 4 funding rounds.
Cosaic is a Swiss biotech food startup developing Cosaic Neo, a patented yeast-fermentation-based ingredient that delivers creaminess, stability, fat, proteins, and fibers in a single, clean-label, non-GMO, allergen-free solution.[4][5] It targets food and beverage manufacturers seeking to enhance plant-based, dairy, sauces, dressings, protein shakes, and coffee creamers without additives or compromises on taste, texture, or nutrition.[4][5] The company solves the challenge of balancing multiple product attributes—taste, feel, nutrition, and stability—in one versatile ingredient, partnering with giants like Ingredion to accelerate commercialization, with first availability slated for 2026.[4][5]
Note: Search results reveal two distinct entities named Cosaic—a legacy fintech firm (formerly ChartIQ, acquired by S&P Global in 2023) focused on financial charting[1][2][3] and this emerging food biotech. This profile addresses the active food tech company (cosaic.bio), as it aligns with current operations, recent partnerships, and future product launches.[4][5]
Cosaic emerged from years of research into yeast fermentation to reimagine food ingredients, led by a team of scientists, engineers, and business experts based in Switzerland.[4][5] Key figures include representatives like Turner, who highlighted the validation of their R&D efforts through partnerships.[4] The idea stemmed from optimizing food systems for resilience and consumer demands, transforming yeast into a multifunctional ingredient that eliminates trade-offs in product formulation.[5] Early traction includes an 18-month observation by Ingredion, culminating in a commercialization partnership for U.S. market entry and co-development, marking a pivotal step from lab innovation to scalable reality.[4]
Cosaic rides the clean-label biotech wave in food tech, addressing surging demand for sustainable, nutrient-dense alternatives amid plant-based and precision fermentation trends.[4][5] Timing is ideal as consumers prioritize natural ingredients post-2020s supply chain disruptions and health-focused shifts, with market forces like regulatory pushes for non-GMO and allergen-free options favoring yeast-derived solutions over synthetic additives.[4] By partnering with established players like Ingredion, Cosaic influences the ecosystem through accelerated innovation, enabling faster portfolio diversification for food giants and paving the way for resilient supply chains that reduce complexity in capitalizing on alt-protein and functional food growth.[4][5]
Cosaic is poised for breakout with Cosaic Neo's 2026 launch, fueled by Ingredion's global distribution and co-development to expand into U.S. sauces, beverages, and beyond.[4][5] Trends like precision fermentation scaling (e.g., similar to Every Company or Oobli) and clean-label mandates will propel growth, potentially evolving Cosaic into a key supplier for resilient food systems.[4] As partnerships deepen, expect broader influence in biotech-food convergence, humanizing nutrition tech while challenging traditional ingredient compromises—echoing its origin as a rule-breaking yeast innovator.[5]
Cosaic has raised $26.9M in total across 4 funding rounds.
Cosaic's investors include Big Idea Ventures, Mandi Ventures, Mayfield, Prime Ventures, SOSV, Albion VC, Gotham Gal Ventures, Illuminate Financial Management, Social Leverage, Roger Ehrenberg.
Cosaic has raised $26.9M across 4 funding rounds. Most recently, it raised $5.0M Seed in March 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2024 | $5.0M Seed | Big Idea Ventures, Mandi Ventures, Mayfield, Prime Ventures, SOSV | |
| Feb 1, 2019 | $17.0M Series B | Albion VC, Gotham Gal Ventures, Illuminate Financial Management, Social Leverage, Roger Ehrenberg | |
| Mar 1, 2016 | $4.0M Series A | Albion VC, Illuminate Financial Management | |
| Nov 1, 2014 | $850K Seed | Gotham Gal Ventures, Social Leverage, Roger Ehrenberg |